REGN Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.

$475.00  -1.36 (-0.29%)
As of 04/09/2021 15:59:59 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/01/2001
Outstanding shares:  105,282,929
Average volume:  930,064
Market cap:   $50,027,289,373
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    75886F107
ISIN:        US75886F1075
Sedol:      2730190

---

Valuation   (See tab for details)

---

PE ratio:   14.24
PB ratio:   4.48
PS ratio:   5.89
Return on equity:   31.86%
Net income %:   41.35%